undervalued growth Report
StockInsight™ Undervalued Growth Stocks Report
🏆 Top Picks
| Rank | Ticker | Price | P/E | EPS Growth | 1D | Verdict |
|---|---|---|---|---|---|---|
| 🥇 | FIS | $42.77 | 6.81x | +3,098% | -0.09% | 🔥 Deep-value growth |
| 🥈 | CDE | $17.39 | 12.86x | +329% | +11.12% | 🔥 Momentum + value |
| 🥉 | ALLY | $43.72 | 10.21x | +309% | -0.77% | ⭐ Recovery growth |
| 4 | AGI | $33.15 | 10.30x | +242% | +6.59% | 🔥 Gold growth |
| 5 | INDV | $38.82 | 13.19x | +228% | +0.39% | ⭐ Healthcare growth |
| 6 | ACAD | $29.21 | 11.66x | +60% | +2.67% | ⭐ Biotech value |
| 7 | UMC | $18.72 | 17.90x | +111% | -2.50% | 🚀 Semiconductor |
| 8 | KGC | $27.64 | 8.96x | +112% | +7.88% | 🔥 Gold value |
| 9 | CF | $114.35 | 10.68x | +46% | -2.04% | ⭐ Cyclical value |
| 10 | CENX | $51.23 | 12.51x | +197% | +11.49% | 🚀 Industrial momentum |
🥇 1. FIS — Fidelity National Information Services
Price: $42.77
Market Cap: $22.1B
P/E: 6.81x
EPS growth: +3,097.94%
Why it screens exceptionally well
FIS is arguably the purest value + growth setup in this universe.
The combination of:
- 6.8x P/E
- enormous EPS improvement
- technology/financial infrastructure exposure
- relatively depressed share price
- large discount to its historical valuation
makes it stand out.
The important caveat is that the enormous EPS-growth number is distorted by the prior-year earnings base, so I would not interpret +3,098% as a sustainable annual growth rate.
StockInsight™ Growth/Value Score: 9.3/10
Classification: 🟢 Deep Value + Earnings Recovery
🥈 2. CDE — Coeur Mining
Price: $17.39
P/E: 12.86x
EPS Growth: +328.93%
1D: +11.12%
CDE is one of the most interesting momentum/value combinations in the list.
The stock is showing:
Price momentum → earnings growth → reasonable valuation
all at the same time.
Why investors are paying attention
- Strong precious-metals environment
- Rapid EPS improvement
- Operating leverage to gold/silver
- Strong trading volume
- Shares remain well below the 52-week high
Risk: commodity prices and mining costs can change the earnings picture quickly.
Score: 9.1/10
Classification: 🟢 High-Growth Commodity Value
🥉 3. ALLY — Ally Financial
Price: $43.72
P/E: 10.21x
EPS Growth: +309.42%
ALLY offers a different type of growth.
This is primarily an earnings normalization / financial recovery story.
Bull Case
- Low valuation
- Strong EPS rebound
- Consumer-finance recovery potential
- Significant operating leverage
- Still below the 52-week high
The market is effectively pricing in considerable cyclicality.
Score: 8.8/10
Classification: 🟢 Financial Recovery Growth
🟢 4. AGI — Alamos Gold
Price: $33.15
P/E: 10.30x
EPS Growth: +241.71%
1D: +6.59%
AGI is particularly interesting because the growth isn’t being accompanied by an excessive valuation.
Setup
10.3x earnings + 242% EPS growth + strong momentum
That’s a compelling combination.
The stock is also trading well below its reported 52-week high of $55.41, giving it substantial room if earnings continue to expand.
Score: 8.9/10
🟢 5. INDV — Indivior
Price: $38.82
P/E: 13.19x
EPS Growth: +227.70%
One of the more interesting non-commodity growth stocks in the universe.
Indivior provides pharmaceutical exposure while maintaining a relatively moderate valuation.
What makes it interesting
- 200% EPS growth
- 13x earnings
- Specialty pharmaceutical exposure
- Strong improvement from its historical earnings base
Score: 8.5/10
Classification: 🟢 Healthcare Growth at Reasonable Valuation
🚀 6. UMC — United Microelectronics
Price: $18.72
P/E: 17.90x
EPS Growth: +110.59%
UMC is one of the better semiconductor value-growth candidates.
Unlike many AI stocks trading at extremely high multiples, UMC remains below 20x earnings.
Investment Theme
Semiconductor cycle recovery + improving earnings + reasonable valuation
The weakness today (-2.50%) actually makes the setup more interesting from a valuation perspective, although momentum has cooled from the strongest levels.
Score: 8.4/10
🟢 7. KGC — Kinross Gold
Price: $27.64
P/E: 8.96x
EPS Growth: +112.33%
1D: +7.88%
KGC is one of the clearest value + commodity momentum names.
At under 9x earnings, the market isn’t assigning a particularly aggressive valuation despite triple-digit EPS growth.
Setup
Low valuation + strong earnings + gold momentum
That’s exactly what an undervalued-growth screen should find.
Score: 8.8/10
🟢 8. ACAD — ACADIA Pharmaceuticals
Price: $29.21
P/E: 11.66x
EPS Growth: +60.43%
ACADIA offers a more traditional growth profile.
Unlike the miners, its earnings potential isn’t directly tied to commodity prices.
Why it qualifies
- 60% EPS growth
- <12x earnings
- Positive price momentum
- Specialty pharmaceutical exposure
Score: 8.2/10
🟢 9. CF — CF Industries
Price: $114.35
P/E: 10.68x
EPS Growth: +45.81%
CF is a classic cyclical value-growth opportunity.
Bull Case
- Fertilizer demand
- Agricultural fundamentals
- Low-cost production
- 10.7x earnings
- Strong EPS improvement
The main issue is today’s -2.04% performance and the cyclical nature of fertilizer prices.
Score: 7.9/10
🚀 10. CENX — Century Aluminum
Price: $51.23
P/E: 12.51x
EPS Growth: +196.52%
1D: +11.49%
This is one of the highest-risk/highest-upside names on the screen.
The combination is striking:
+197% EPS growth + 12.5x P/E + 11.5% daily gain
CENX also has significant exposure to the aluminum/industrial cycle.
Score: 8.4/10
Classification: 🟡 High-Beta Cyclical Growth
💎 Other Stocks Worth Watching
| Ticker | P/E | EPS Growth | Why Interesting |
|---|---|---|---|
| FSLR | 15.02x | +38.6% | Solar manufacturing growth |
| TECK | 16.54x | +840% | Metals + exceptional earnings recovery |
| MPC | 10.87x | +329.5% | Refining earnings leverage |
| NTR | 14.00x | +363.8% | Agriculture/fertilizer |
| HMY | 10.49x | +54.5% | Gold leverage |
| AEM | 12.62x | +98.7% | High-quality gold producer |
| SSRM | 9.79x | +157.7% | Gold/silver recovery |
| CMC | 13.80x | +1,570% | Steel/infrastructure recovery |
| THC | 9.71x | +64.5% | Healthcare earnings growth |
| ARIS | 10.77x | +5,762% | Extremely high-risk mining growth |
⚠️ Stocks I Would NOT Automatically Call “Undervalued Growth”
A low P/E alone doesn’t make a growth stock.
T — AT&T
7.66x P/E / +72% EPS
Cheap, but the fundamental profile is more income/value than growth.
AGNC
5.65x P/E / +631% EPS
The EPS number is heavily influenced by the mortgage/REIT accounting environment. Not comparable to conventional operating-company growth.
NLY
5.74x P/E / +296% EPS
Similar issue: attractive valuation, but primarily an income/rate-sensitive mortgage REIT.
ORC
4.59x P/E / +1,890% EPS
Extremely misleading as a conventional growth screen because of the underlying mortgage-REIT business model.
🧠 StockInsight™ Growth-Value Matrix
🔥 Best Overall
FIS
CDE
AGI
KGC
ALLY
🚀 Higher-Growth / Higher-Risk
CENX
TECK
ARIS
UMC
SSRM
🛡️ More Defensive Growth
ACAD
INDV
THC
FSLR
💰 Value Rather Than Growth
T
AGNC
NLY
BCE
PBR
🎯 StockInsight™ Top 10
| Rank | Stock | Style | Score |
|---|---|---|---|
| 🥇 | FIS | Deep Value + Growth Recovery | 9.3 |
| 🥈 | CDE | Commodity Growth + Momentum | 9.1 |
| 🥉 | AGI | Gold Growth + Value | 8.9 |
| 4 | KGC | Gold Value + Growth | 8.8 |
| 5 | ALLY | Financial Recovery | 8.8 |
| 6 | INDV | Healthcare Growth | 8.5 |
| 7 | UMC | Semiconductor Growth | 8.4 |
| 8 | CENX | Industrial Growth | 8.4 |
| 9 | ACAD | Biotech Growth | 8.2 |
| 10 | CF | Agricultural/Cyclical Growth | 7.9 |
🔎 Bottom Line
The three most interesting setups from this particular dataset are:
FIS → CDE → AGI
- FIS: cheapest fundamental growth opportunity
- CDE: strongest combination of earnings growth and price momentum
- AGI: attractive gold exposure with substantial EPS growth at ~10x earnings
The biggest distinction is that FIS/ALLY/ACAD/INDV are operating-company growth/recovery stories, while CDE/AGI/KGC/SSRM are commodity-leveraged growth stories. I would not treat the two groups as equivalent risks.
